SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
for the period ended 20 July, 2006
BP p.l.c.
(Translation of registrant's name into English)
1 ST JAMES'S SQUARE, LONDON, SW1Y 4PD, ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F |X| Form 40-F
--------------- ----------------
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes No |X|
--------------- ----------------
July 20, 2006
BP BOARD APPOINTMENT - SIR WILLIAM CASTELL
The board of BP announced today that Sir William Castell has been appointed as a
non-executive director with immediate effect.
Sir William, 59, has had an extensive career in the healthcare industry, notably
as Chief Executive for 16 years of Amersham International, followed by his
appointment as Vice Chairman to the board of GE and responsibility for GE's
global healthcare business. Sir William stepped down from this post in April of
this year when he became Chairman of the Wellcome Trust. He remains a Director
(non-executive) of GE and is a Trustee of the Natural History Museum.
Sir William will join both the audit committee and the ethics and environment
assurance committee.
Notes to Editors:
GE (NYSE: GE) is a diversified technology, media and financial services company
dedicated to creating products that make life better. From aircraft engines and
power generation to financial services, medical imaging, television programming,
and plastics, GE operates in more than 100 countries and employs more that
300,000 people worldwide. For more information, visit www.ge.com
The Wellcome Trust is the most diverse biomedical research charity in the world,
spending about GBP450 million every year both in the UK and internationally to
support and promote research that will improve the health of humans and animals.
The Trust was established under the will of Sir Henry Wellcome, and is funded
from a private endowment, which is managed with long-term stability and growth
in mind. For more information visit www.wellcome.ac.uk
Further information:
BP Press Office, London tel: +44 (0)207 496 4076
- ENDS -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
BP p.l.c.
(Registrant)
Dated: 20th July, 2006 /s/ D. J. PEARL
..............................
D. J. PEARL
Deputy Company Secretary